Otros idiomas ODI Pharma AB

Acciones

ODI

SE0013409760

Precio de cierre NORDIC GROWTH MARKET Otros sitios de cotización 00:00:00 03/05/2024			Varia. Cinco días.	Varia. 1 de enero.
7,65 ^SEK	+18,60 %		+34,21 %	+53,00 %

02/05	ODI Pharma AB proporciona una previsión de ventas para el tercer trimestre del año 2024	CI
22/02	ODI Pharma AB (publ) informa de los resultados del segundo trimestre y seis meses finalizados el 31 de diciembre de 2023	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Preliminary results for ODI Pharma indicate significant revenue increase in Q3 2023/2024	02/05
ODI Pharma AB Provides Sales Guidance for the Third Quarter of the Year 2024	02/05
ODI Pharma AB Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	22/02
Announcement from the Annual General Meeting in ODI Pharma AB (publ)	15/12
ODI Pharma Sells CBD Skincare Brand for SEK3 Million	06/12
ODI Pharma AB announces sale of the skincare brand kandol. for 3.2 msek	06/12
ODI Pharma AB publishes the annual report for the fiscal year 2022/2023	24/11
ODI Pharma AB Reports Earnings Results for the First Quarter Ended September 30, 2023	24/11
ODI Pharma AB postpones publication of interim report and annual report until November 24, 2023	23/11
Notice to Annual General Meeting in ODI Pharma AB (publ)	13/11
ODI Pharma AB: Publication of year-end report for the fiscal year 2022/2023	24/08/23
ODI Pharma AB Reports Earnings Results for the Fourth Quarter and Full Year Ended June 30, 2023	24/08/23
ODI Pharma’s Stock Soars After Exclusive Supplier Deal With Synoptis Pharma	07/08/23
ODI Pharma AB enters into exclusive collaboration with Synoptis Pharma Sp. z o.o.	07/08/23
ODI Phaa AB Enters into Exclusive Collaboration with Synoptis Pharma Sp. Z o.o	07/08/23
ODI Pharma AB receives loan financing of EUR 350,000	01/06/23
ODI Pharma AB Receives Loan Financing of EUR 350,000	01/06/23
ODI Pharma AB: Publication of interim report report Q3 2022/2023	25/05/23
ODI Pharma AB Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023	25/05/23
ODI Pharma AB: Publication of half-year report 2022/2023	23/02/23

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas ODI Pharma AB

Acciones

ODI

SE0013409760

Otros idiomas

Filtros